Flagship Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$214K Buy
1,662
+963
+138% +$113K 0.05% 147
2026
Q1
$55.3K Sell
699
-663
-49% -$76.5K 0.02% 192
2025
Q4
$143K Sell
1,362
-331
-20% -$31.1K 0.04% 140
2025
Q3
$142K Sell
1,693
-1,156
-41% -$95.2K 0.05% 142
2025
Q2
$226K Hold
2,849
0.09% 106
2025
Q1
$256K Hold
2,849
0.11% 96
2024
Q4
$283K Buy
+2,849
New +$294K 0.17% 75

Other funds holding MRK

Flagship Wealth Advisors's MRK Position: Q2 2026 in Review

Flagship Wealth Advisors increased its Merck (MRK) stake by 138% in Q2 2026, buying an estimated $113K and bringing the position to 1,662 shares worth $214K. The position accounts for 0.05% of the portfolio, ranked #147.

Flagship Wealth Advisors first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $283K in Q4 2024. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Flagship Wealth Advisors held 1,662 shares of Merck worth $214K as of Q2 2026.
  • Flagship Wealth Advisors bought 963 Merck shares in Q2 2026, an estimated $113K.
  • Merck made up 0.05% of Flagship Wealth Advisors's portfolio in Q2 2026, its #147 holding.
  • Flagship Wealth Advisors first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Flagship Wealth Advisors's Merck position peaked at $283K in Q4 2024.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Flagship Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.